1. Epistasis in neurotransmitter receptors linked to posttraumatic stress disorder and major depressive disorder comorbidity in traumatized Chinese
   Ling Xu et al, 2024, Frontiers in Psychiatry CrossRef
2. Investigation of the protective effect of resveratrol in an MK-801-induced mouse model of schizophrenia
   Murat Sırrı Akosman et al, 2021, Environmental Science and Pollution Research CrossRef
3. Bioavailability of Tannins and Other Oligomeric Polyphenols: a Still to Be Studied Phenomenon
   Naira Sahakyan et al, 2020, Current Pharmacology Reports CrossRef
4. Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence
   Katarzyna Socała et al, 2024, Phytotherapy Research CrossRef
5. Natural Phytochemicals for the Treatment of Major Depressive Disorder: A Mini-Review of Pre- and Clinical Studies
   Gislaine Z. Réus et al, 2023, CNS & Neurological Disorders - Drug Targets CrossRef
6. Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery
   Yu-Qiong He et al, 2024, Frontiers in Pharmacology CrossRef
7. Resveratrol reduces the progression of titanium particle‑induced osteolysis via the Wnt/β‑catenin signaling pathwayin vivoandin vitro
   Xi Chen et al, 2021, Experimental and Therapeutic Medicine CrossRef
8. Folate supplementation as a beneficial add‐on treatment in relieving depressive symptoms: A meta‐analysis of meta‐analyses
   Shan Gao et al, 2024, Food Science & Nutrition CrossRef
9. Polyphenols in edible herbal medicine: targeting gut-brain interactions in depression-associated neuroinflammation
   Wenzhi Hao et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef
10. Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
    Maha Nasr et al, 2023, Metabolic Brain Disease CrossRef